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Editorial comment  Translational medicine is a new discipline which aims to eliminate the barrier between preclinical and 
clinical medicine. Here, Dr. Li discusses the application of translational medicine in the research, teaching and clinical work of 
Prof. Liu Shih-Hao, the founder of endocrinology in China, who was particularly renowned for his early work in calcium and 
phosphorus metabolism. This well-known success story can be traced back to an early appreciation of translational medicine 
by Prof. Liu Shih-Hao, and serves as an important and revelatory lesson for us all. 
translational medicine, Liu Shih-Hao 
 




Translational medicine as a unique discipline formally 
evolved from the translational research of the last century. Its 
objective is to apply the results of preclinical medicine di-
rectly to clinical medicine, and also to identify challenges in 
clinical medicine for further mechanistic studies in the labor-
atory in order to develop new methods to address these clini-
cal problems. In a short phrase, the essence of translational 
research is “Bench to Bedside and Bedside to Bench” [1]. 
Although translational research has only relatively recently 
been formally declared a new discipline in the first issue of 
the Journal of Translational Medicine in 2003, the principles 
behind translational medicine have existed much longer. By 
delving into the history of medicine from the first half of the 
20th century, it is clear that Prof. Liu Shih-Hao (刘士豪), the 
founder of endocrinology in China, did develop his research, 
teaching and clinical work according to these fundamental 
principles of translational medicine. 
1  Brief introduction of Dr. Liu Shih-Hao 
Liu Shih-Hao (1900–1974) (Figures 1 and 2) was born in 
Wuchang County, Hubei Province of China in 1900. He en-
tered Boone Middle School, which was a missionary school, 
in 1913 where he completed six years of courses in only four 
years. He joined the Premedical School of Hunan-Yale Medi-
cal College in 1917, and transferred to the Premedical School 
of Peking Union Medical College (PUMC) in 1919 and the 
Medical School in 1920. He graduated in 1925, receiving a 
Medical Doctor degree from New York State University, and 
the Wenham Prize for having the highest total score.  
In his last year as a medical student at PUMC, Liu 
Shih-Hao wrote his first paper entitled “The Influence of 
Cod Liver Oil on the Calcium and Phosphorus Metabolism 
in Tetany” [2], which was published in the China Medical 
Journal. This paper reflected his strong interest in endocri-
nology, and the Department of Internal Medicine of PUMC 
Hospital naturally accepted him after graduation. Liu was 
the first graduate from PUMC to work in this department. 
From 1925 to 1928 Liu served as intern, resident, chief 
resident and attending physician. He published 13 papers 
during that period, on topics ranging from hypoglycemia to 
acid-base balance of malaria, which laid a solid foundation 
for his clinical research. 
From 1928 to 1930, Liu worked at the Rockefeller Insti-
tute of Medicine as a visiting scholar, where he studied 
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metabolic disease and blood gas analytical techniques under 
renowned biochemist D. D. Van Slyke. He and his col-
leagues established a method for determining pH, the con-
centration of CO and CO2 tension in blood samples, and a 
new method for research into the acid-base balance of 
blood.  
After returning to China in 1930, Liu focused his re-
search on calcium and phosphorus metabolism. He became 
the leader of the research group on this discipline after R. R. 
Hannon returned to the United States in 1934. He and other 
members of this group, including Chu Hsieh-I, Wang 
Shu-Hsien, Chou Shou-Kai and Yu Tsai-Fan, published a 
series of papers on the bone disease osteomalacia. These 13 
papers, collectively entitled “Calcium and Phosphorus Me-
tabolism of Osteomalacia” [3–15] described many features 
of osteomalacia, from the influence of food to the function 
of vitamin D, and made a unique move into the realm of 
bone metabolism, marking an important discovery for in-
ternational endocrinology. A. Parfitt, the well-known endo-
crinologist, highly appraised Liu and his colleagues’ re-
search in a special article commemorating Prof. Chu 
Hsien-I [16], “for many years the PUMC papers constituted 
the world’s entire stock of knowledge concerning the met-
abolic aspects of human privational vitamin D deficiency 
and its treatment”. 
One of the more outstanding achievements of Liu’s re-
search on calcium and phosphorus metabolism during this 
period was the nomination of the disease “renal osteo-
dystrophy”. In April 1942, Liu Shih-Hao and Chu Hsien-I 
published an article [17] in the journal Science proposing 
the name “renal osteodystrophy” and the effectiveness of 
treatment by dihydrotachysterol (A.T.10). Different from 
the traditional nominations of syndromes based on phe-
nomenology, the name “renal osteodystrophy” reflects the 
nature of the disease, which has assured its wide-spread 
adoption that continues to this day.  
During the same period, Liu Shih-Hao diagnosed and 
treated the first Chinese case of insulinoma, and performed 
some detailed metabolic research with the cooperation of 
Loucks, who was the head of the Department of Surgery. 
The paper reporting their findings [18] was published in the 
prestigious Journal of Clinical Investigation.  
From 1938 to 1939, Liu Shih-Hao was in London, and 
systematically performed animal experiments under Edward 
Charles Dodds, the famous scholar of the Courtauld Insti-
tute of Biochemistry at Middlesex Hospital. With the coop-
eration of R. L. Noble, he stimulated the hypophysecto-
mized Wistar rats with pregnant mare serum and human 
pregnancy urine, and observed the resultant changes in the 
male/female reproductive system, thus paving the way for 
endocrine research in laboratory animals [19,20].  
In 1941, Liu Shih-Hao became the first professor in 
PUMC among PUMC graduates. However, he was forced to 
practice medicine at the end of that year because PUMC 
was occupied by the Japanese army. When the Second 
World War ended, Liu Shih-Hao was invited to be the Chief 
of Internal Medicine at Tongren Hospital, a special doctor at 
the Peking Army Hospital, and in 1948 he became the 
President of Tongren Hospital. After the rehabilitation of 
PUMC, he went back to work at the PUMC Hospital. After 
the Korean War broke out, Liu Shih-Hao became head of 
the Biochemistry Department at the Medical College, while 
still an internal professor at the PUMC Hospital and Presi-
dent of Tongren Hospital. While working in the Biochemistry 
Department, he spent a lot of time developing a method for 
testing hormones. During that time, his book entitled The 
Connection Between Biochemistry and Clinical Medicine (in 
Chinese) [21], was published, which has influenced a genera-
tion of doctors working in internal medicine.  
In 1958, Liu Shih-Hao quit his jobs in the Biochemistry 
Department and Tongren Hospital, and built an endocrinol-
ogy department at the PUMC Hospital, becoming its first 
Chief. At the beginning of the 1960s, Prof. Liu Shih-Hao 
observantly noted the potential importance of the invention 
of radioimmunoassays for endocrinology, and decided to 
develop the method immediately, which he completed in 
1965. At the same time, he led the survey of diabetes melli-
tus incidence in workers from the Capital Iron and Steel 
Works, and built a solid foundation for the following epi-
demiology survey and research on diabetes mellitus in our 
country. Besides all of this, he opened four senior seminars  
 
 
Figure 1  Liu Shih-Hao was doing the experiment. 
 
Figure 2  Liu Shih-Hao and his wife Wang E-Tsung (1957). 
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at the beginning of the 1960s, which trained teachers and 
researchers throughout the country. 
In June 1974, Prof. Liu Shih-Hao, impacted by the Cul-
tural Revolution, was wronged and driven to death. 
Prof. Liu Shih-Hao was the founder and pioneer of en-
docrinology in China, and his acknowledgement of the 
principles behind translational medicine helped him to 
achieve these significant contributions to science and medi-
cine. 
2  The translational medical aspect of Liu 
Shih-Hao’s research on calcium and phosphorus 
metabolism 
In Prof. Liu Shih-Hao’s article on calcium and phosphorus 
metabolism, we have already seen the principles of “Bench 
to Bedside and Bedside to Bench”, even though the concept 
of translational medicine had not been formally defined.  
In 1930’s China, one of the main clinical problems was 
the high morbidity of osteomalacia, particularly in the north. 
Osteomalacia is a disease caused by defective bone miner-
alization which manifests as bone ache, skeleton deformity 
and bone fractures. Complications include delivery failure 
caused by deformity of the pelvis and tetany of the neuro-
musculature. The most severely affected patients become 
disabled and unable to take care of themselves. It was be-
lieved that lack of sunshine in northern China was the cause 
of osteomalacia. The Chief of the Department of Gynecol-
ogy and Obstetrics at PUMC, J. P. Maxwell, published an 
article [22] entitled “Osteomalacia in China”, which dis-
cussed this problem in detail. When Liu Shih-Hao began to 
study calcium and phosphorus metabolism, the vitamin D 
deficient animal model [23] had been established, and was 
treatable with vitamin D. The aim of translational medicine 
is to convert insight gained from preclinical medicine to 
therapeutic options for the clinic. Liu Shih-Hao and his re-
search group published serial articles entitled “Calcium and 
Phosphorus Metabolism in Osteomalacia” [3–15]. In the 13 
papers, they discussed in depth the treatment and prevention 
of osteomalacia, resulting in effective treatments for osteo-
malacia, which was particularly important for pregnant and 
nursing women. 
By investigating the specific content of this work, we can 
identify research topics that fit in with modern translational 
medicine. The subtitles of these 13 papers are 
(i) The effect of vitamin D and its apparent duration; 
(ii) Further studies on the response to vitamin D of pa-
tients with osteomalacia; 
(iii) The effects of varying levels and ratios of intake of 
calcium to phosphorus on their serum levels, paths of excre-
tion and balances; 
(iv) Report of an unusual case in a male with acute para-
thormone poisoning; 
(v) The effect of varying levels and ratios of calcium to 
phosphorus intake on their serum levels, paths of excretion 
and balances in the presence of continuous vitamin D ther-
apy; 
(vi) The added drain of lactation and beneficial action of 
vitamin D; 
(vii) The effect of ultraviolet irradiation from mercury 
vapor quartz lamp and sunlight; 
(viii) The effects of ingestion of acid and alkali in pa-
tients with and without chronic nephritis; 
(ix) Metabolic behavior of infants fed on breast milk 
from mothers showing various states of vitamin D nutrition; 
(x) Further studies on vitamin D action: Early signs of 
depletion and effect of minimal doses; 
(xi) The pathogenetic role of pregnancy and relative im-
portance of calcium and vitamin D supply; 
(xii) Studies of calcium and phosphorus metabolism with 
special reference to pathogenesis and effect of dihydrota-    
chysterol (A.T. 10) and iron; 
(xiii) The availability of inorganic phytin, and dietary 
phosphorus and the effect of vitamin D. 
The main research area of Liu Shih-Hao et al. in the Me-
tabolism Ward of the PUMC Hospital was the detailed 
metabolic analysis of osteomalacia patients. The team ac-
curately measured the quantities of calcium and phosphorus 
intake from food and drinks, and excretion in urine and 
stool, in these patients. The meals were prepared in dupli-
cate so one portion could be analyzed in the laboratory for 
levels of calcium and phosphorus. After a period of 4 d, 
serum calcium and phosphorus levels were measured for 
each patient to monitor changes. By observing the metabo-
lism of calcium and phosphorous during different periods of 
food and drug treatments, they could make conclusions re-
garding the underlying pathophysiological mechanisms in 
order to develop the best therapeutic regimen. For example, 
in “Calcium and Phosphorus in Osteomalacia (V): The Ef-
fect of Varying Levels and Ratios of Calcium to Phosphorus 
Intake on Their Serum Levels, Paths of Excretion and Bal-
ances in the Presence of Continuous Vitamin D Therapy” [7] 
published in the Journal of Clinical Investigation in 1937, 
an osteomalacia patient receiving continuous vitamin D 
therapy was analyzed for changes in calcium and phospho-
rous metabolism when eating different foods. Figure 1 
shows these changes in calcium and phosphorus levels: The 
solid line represents serum calcium levels; the dashed line 
represents the intake of calcium and phosphorus levels; the 
open bars indicate the quantity of calcium and phosphorus 
in stool; the shaded bars indicate the excretion of calcium 
and phosphorus in urine. There were 12 types of food given 
to these patients, containing three different amounts of cal-
cium and four different amounts of phosphorus. The pa-
tients ate each type of food for three defined metabolic pe-
riods. Serum calcium and phosphorus levels were analyzed 
in the morning at the beginning of each period, and the 
urine and stool excreted during each period were also tested 
for calcium and phosphorus levels. Figure 1 shows that the 
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serum calcium levels were quite stable, but the serum 
phosphorus level changed dramatically. For example, in the 
15th period, serum phosphorus levels rose by 5.3 mg dL1, 
and, while the calcium intake remained at a high level, 
phosphorus intake gradually increased with no calcium 
tested in urine, and phosphorus excretion increased in urine 
but kept steady in stool. Liu Shih-Hao analyzed each meta-
bolic period in order to make conclusions regarding calcium 
and phosphorus metabolic balance. At the same time, they 
performed an analogous study in syphilis ostitis patients 
(who were not taking vitamin D), who displayed no obvious 
metabolic changes and were used as a control. The major 
important conclusion from this work was that when using 
vitamin D as a preclinical treatment, a 2:1 ratio of calcium 
and phosphorus in food was most effective for deposition in 
bone. Thus, given the low levels of calcium in Chinese food, 
calcium supplementation was required. Liu Shih-Hao and 
his research group made many more useful conclusions 
from these studies, converting this preclinical medical study 
into practical therapeutic approaches for clinical medicine, 
thus providing clear examples of translational medicine. 
The National Institute of Health (NIH) defines two stages 
in translational medicine: The first stage is confirming la-
boratory findings in animals and humans; the second is 
moving these results into clinical practice, in order to find 
the best therapy for the clinic. The research study of Liu 
Shih-Hao belonged to the second stage of translational 
medical research, as he investigated the importance of food 
composition for patients receiving vitamin D therapy in 
order to promote the best possible recovery. In addition, the 
analysis of serum calcium and phosphorus level and their 
quantities in stool and urine is more of a basic laboratory 
study. In the 1930s, at the PUMC Hospital, the metabolic 
research of Liu Shih-Hao was required to combine preclini-
cal and clinical medicine. Thus, “Bench to Bedside and Bed-
side to Bench” was not only a concept, but also a reality. In 
addition, the preclinical study of Prof. Wu Hsien on nutri-
ology in the Biochemistry Department, demonstrated the  
 
 
Figure 3  Calcium and phosphorus metabolism and their serum levels in relation to varying intake of calcium and phosphorus in ref. [7]. 
 Li N S.   Sci China Life Sci   December (2011) Vol.54 No.12 1093 
calcium and phosphorus quantities in common foods, which 
also helped Liu Shih-Hao make his final conclusions and 
illustrates the essence of translational medicine.  
The most outstanding contribution in the field of bone 
metabolism was “renal osteodystrophy” which was named 
by Liu Shih-Hao and Chu Hsieh-I, and successfully treated 
with A.T.10. The success of this work again comes from the 
consideration and practice of translational medicine. Liu 
Shih-Hao and his research group performed a metabolic 
study on chronic renal failure patients accompanied by os-
teomalacia [24], and found that the essence of this disease 
was a secondary bone mineralization disorder caused by 
chronic renal failure and a calcium and phosphorus meta-
bolic disorder. Therefore, they unified the present nomen-
clature and introduced the disease as “renal osteodystrophy”. 
Because of the simplicity and accuracy of this name, it was 
widely accepted by academic circles and is still used now. 
A.T.10 was another medicine that could be used to treat 
nutritional osteomalacia. The mechanism is essentially the 
same as vitamin D, but for renal osteodystrophy patients 
treatment with vitamin D is highly problematic, thus an al-
ternative option was required. Liu Shih-Hao and Chu 
Hsieh-I treated these patients with A.T.10 and recorded 
their metabolic profiles to reveal that a regular dose of 
A.T.10 was an effective therapy for renal osteodystrophy. In 
addition, they made a further discovery within the realms of 
translational medicine, specifically in clinical practice. As 
A.T.10 was effective in renal osteodystrophy while vitamin 
D was not, they hypothesized that chronic renal failure  
could affect the activity of vitamin D but not A.T.10. This  
raised questions about vitamin D and kidney physiology,  
which, while not answered at the time, was investigated  
some thirty years later by the American chemist Deluca [25],  
who also identified the active form of vitamin D in vitro,  
which is 1,25-(OH)2VitD. This discovery led to the indus- 
trial production of 1,25-(OH)2VitD and its use as a common  
therapeutic medicine to treat osteomalacia and renal osteo- 
dystrophy in the clinic, illustrating once again the successful  
application of “Bedside to Bench and Bench to Bedside”. 
3  The reflection of translational medicine in 
other work of Liu Shih-Hao 
In 1934, Liu Shih-Hao successfully diagnosed and treated  
the first Chinese case of insulinoma in the Metabolism De- 
partment at PUMC [18]. After surgically removing the tu- 
mor from the patient, Liu injected tumor extract into a rab- 
bit, and analyzed its insulin content by measuring the de- 
crease in blood glucose levels. Thus, he performed an insu- 
lin bioassay and diagnosed insulinoma in an experimental  
animal, thereby practicing an alternative form of transla- 
tional medicine.  
During 1938 when Liu Shih-Hao was trained in London,  
he spent most of his time studying experimental animal re- 
search. Together with his colleagues, he stimulated Wistar  
rats, whose pituitary glands had been removed, with preg- 
nant horse serum and pregnant women’s urine, which has  
developed into a method to facilitate ovulation and sper- 
matogenesis using human chorionic gonadotrophin. 
In 1951, Liu Shih-Hao became Head of the Department of  
Biochemistry at PUMC, internal professor at PUMC Hospital  
and President of Beijing Tongren Hospital, which illustrates  
his expertise in both the preclinical and clinical arenas. 
In 1957, The Connection Between Biochemistry and  
Clinical Medicine (in Chinese) written by Liu Shih-Hao was  
published [20]. It discussed calcium and phosphorus me- 
tabolism and osteopathy, sodium and potassium metabolism,  
diabetes mellitus, and endocrinal diseases in thyroid, pitui- 
tary and adrenal glands from a biochemical and physiologi- 
cal perspective. For many years, every internal doctor  
working in hospitals across Peking carried a copy of this  
book. Unfortunately, the plan to reprint it was aborted be- 
cause of the Cultural Revolution. 
In 1958, Liu Shih-Hao combined his research group in  
the Department of Biochemistry at PUMC with the internal  
endocrine group at PUMC Hospital, founding the Endocrine  
Department, where he became Head of Department. This  
amalgamation further cemented the relationship between  
preclinical and clinical medicine, facilitating the practice of  
translational medicine. 
During his time as Chief of the PUMC Biochemistry  
Department, the main focus of Liu Shih-Hao’s research was  
establishing a method to detect hormone, which was a 
common problem in the clinic. Most endocrine diseases are 
hyperhormonism or hypohormonism, but at that time the 
diseases could only be diagnosed by manifestations caused  
 
 
Figure 4  The Connection Between Biochemistry and Clinical Medicine 
(in Chinese). 
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by the disorder of hormone and were influenced by subjec-
tivity. Thus, being able to precisely detect hormone in blood 
(or urine) would significantly improve the diagnosis of en-
docrine diseases. The method for detecting 24-hour urine 
17-hydroxycorticosteroids was established by Liu Shih-Hao 
in 1957, which improved the diagnosis of adrenal diseases. 
In 1960, American scientists Yalow and Berson established 
a radioimmunoassay to detect insulin, which improved the 
precision of hormone detection by several orders of magni-
tude, and was hailed as a milestone in the history of the en-
docrinal medical field [26]. When Liu Shih-Hao learned of 
this progress in China, he realized its significance and began 
to study the method himself, finishing its setup in 1965. He 
also planned to detect other hormones by radioimmunoas-
say, but by then the Cultural Revolution meant he could not 
continue this work. After the Cultural Revolution, the third 
Chief of the Endocrine Department, Prof. Shi Yi-Fan, fin-
ished the work in the 1980s, which further revised the level 
of clinical diagnosis for endocrinal diseases. Therefore, the 
translational medicine approach of Liu Shih-Hao has had a 
deep influence on Chinese endocrinology. 
4  The history behind Liu Shih-Hao’s transla-
tional approach to medicine 
4.1  The translational approach of Liu Shih-Hao was 
likely influenced by the international reformation of 
medical education 
In 1910, the Flexner report published in the USA recom-
mended an overhaul of American medical education. The 
report used Johns Hopkins University School of Medicine as 
an ideal foundation for reforming mainstream medical edu-
cation. As a result, it closed the gap between biology, pre-
clinical medicine and clinical medicine. This trend of 
thought in American medical education was highly ad-
vanced, helping to make them world leaders in biology and 
medicine. The Peking Union Medical College (PUMC) is a 
private medical college founded by the Rockefeller financial 
group from the USA. The aim was to establish PUMC as a 
“Johns Hopkins School of Medicine” in the Far East. Liu 
Shih-Hao was the second graduate of PUMC and deeply 
influenced by this connection, as well as having studied at 
the Rockefeller Institute from 1928 to 1930, which helped 
him to develop a translational approach to his work. 
4.2  Liu Shih-Hao had high scholarly achievements in 
preclinical and clinical medicine 
At PUMC, Liu Shih-Hao mainly studied clinical medicine, 
while also in contact with preclinical medicine professors 
such as Wu Hsien and Robert KhoSeng Lim. Liu Shih-Hao 
graduated first in his class from PUMC and worked in the 
PUMC Hospital for three years in a relatively preclinical 
area, from which he gained substantial clinical experience. 
He joined biochemist D. D. Van Slyke at the Rockefeller 
Institute, enriching his knowledge of biochemistry and de-
veloping experimental techniques. He gained a lot from this 
experience, which was undoubtedly very valuable for his 
research on calcium and phosphorus metabolism when he 
returned to China. In 1938, Liu Shih-Hao learned experi-
mental animal techniques in London, which was very ad-
vanced fundamental research at that time and also important 
for translational medicine. Therefore, Liu Shih-Hao’s re-
markable achievements both in preclinical and clinical 
medicine set the stage for his work in translational medi-
cine. 
4.3  Liu Shih-Hao’s pursuit of translational medicine 
was aided by his working environment 
The main reason that Liu Shih-Hao could successfully per-
form translational medicine was the privileged environment 
at PUMC. The best example of this was the establishment 
of renal osteodystrophy and its treatment. The Metabolism 
Ward in which Liu Shih-Hao worked took as a foundation 
the world renowned Ward IV at Massachusetts General 
Hospital, which is affiliated with Harvard Medical School 
in the USA, of which Fuller Albright made many important 
discoveries within the field of translational medicine. 
4.4  The work of Liu Shih-Hao’s predecessors provided 
the foundation for his research in translational medicine 
As mentioned above, the work of Maxwell in epidemiology 
revealed the importance of osteomalacia in China. Bio-
chemist Wu Hsien was Head of the Biochemistry Depart-
ment at PUMC, and his research on Chinese diet led to the 
work of Liu Shih-Hao on metabolism, and is also an im-
portant example of translational medicine. At the same time, 
vitamin D was discovered. Thus, in the 1930s the conditions 
for the study of osteomalacia matured, and the best place to 
do this work was at PUMC. 
4.5  The divide between preclinical and clinical medi-
cine was not that great 
Neither the complexity nor the study scope of the preclini-
cal medicine research in the early 20th century could com-
pare with the current condition. Consequently, during the 
time of Liu Shih-Hao’s career, it was possible to be both a 
preclinical and clinical expert and study translational medi-
cine. Liu Shih-Hao was Chief of the Biochemistry Depart-
ment in preclinical medicine and then became Chief of the 
Endocrine Department in clinical medicine. This combina-
tion of position has never recurred in China. However, re-
cently an emphasis has been placed on collaborations be-
tween experts from preclinical and clinical areas, highlight-
ing its value. 
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5  Conclusion 
The ideology of Prof. Liu Shih-Hao within his research, 
clinical work and teaching, which he followed for a lifetime 
is identical to the current popular trend towards translational 
medicine. The renowned success attained by Prof. Liu 
Shih-Hao in translational medicine is both important and 
revelatory for all of us. 
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